2023
Tobacco use and cancer‐related symptom burden: Analysis of the US Population Assessment of Tobacco and Health Study
Price S, Palmer A, Fucito L, Graboyes E, Baker N, Rojewski A, Toll B. Tobacco use and cancer‐related symptom burden: Analysis of the US Population Assessment of Tobacco and Health Study. Cancer 2023, 129: 2385-2394. PMID: 37211959, PMCID: PMC10593116, DOI: 10.1002/cncr.34746.Peer-Reviewed Original ResearchConceptsSymptom burdenCurrent smokingCigarette smokingQuit attemptsTobacco useGreater fatiguePast-year quit attemptsCancer symptom burdenUS Population AssessmentCurrent cigarette smokingGreater symptom burdenTobacco treatment interventionsAdult cancer survivorsQuality of lifeSmoking quit attemptEmotional problemsRace/ethnicityCancer survivorsTobacco cessationHealth StudySmokingTreatment interventionsUS FoodMultivariate analysisSurvivors' interest
2020
Tobacco Treatment Program Models in US Hospitals and Outpatient Centers on Behalf of the SRNT Treatment Network
Palmer AM, Rojewski AM, Chen LS, Fucito LM, Galiatsatos P, Kathuria H, Land SR, Morgan GD, Ramsey AT, Richter KP, Wen X, Toll BA. Tobacco Treatment Program Models in US Hospitals and Outpatient Centers on Behalf of the SRNT Treatment Network. CHEST Journal 2020, 159: 1652-1663. PMID: 33259805, PMCID: PMC8039006, DOI: 10.1016/j.chest.2020.11.025.Peer-Reviewed Original ResearchConceptsTobacco treatment programOutpatient centerTreatment programSmoking cessation treatmentTobacco cessation servicesTreatment modelUS health care systemEvidence of feasibilityHealth care systemCause of diseaseCessation servicesCessation treatmentMedical systemTobacco useDissemination trialUS hospitalsMedical providersClinical researchHospitalTreatment networkHigh-impact opportunityReviewPatientsMortalityIllustrative review
2019
Electronic cigarette and tobacco use in individuals entering methadone or buprenorphine treatment
Baldassarri SR, Fiellin DA, Savage ME, Madden LM, Beitel M, Dhingra LK, Fucito L, Camenga D, Bollampally P, Barry DT. Electronic cigarette and tobacco use in individuals entering methadone or buprenorphine treatment. Drug And Alcohol Dependence 2019, 197: 37-41. PMID: 30769264, PMCID: PMC6637405, DOI: 10.1016/j.drugalcdep.2018.12.012.Peer-Reviewed Original ResearchConceptsOpioid use disorderOpioid agonist therapyCurrent cigarette smokingCigarette smokingEC useHigher oddsFormer smokersLower oddsPsychiatric distressPast cigarette smokingElectronic cigarette useAgonist therapyCurrent smokersBuprenorphine treatmentChronic painTobacco useNicotine dependenceUse disordersSmokingCigarette useMultivariate analysisElectronic cigarettesSmokersCigarettesMultivariate model
2018
Chapter 12 Tobacco Use Disorder and Treatment
Fucito L, Baldassarri S. Chapter 12 Tobacco Use Disorder and Treatment. 2018, 183-196. DOI: 10.1016/b978-0-323-48565-4.00012-6.Peer-Reviewed Original ResearchTobacco use disorderLung cancer outcomesUse disordersOncology providersTobacco cessationCancer outcomesLung cancerTobacco useLong-term quit ratesBrief cessation adviceTobacco cessation interventionsTobacco cessation treatmentClinical practice guidelinesLung cancer patientsMajor risk factorLung cancer riskImportant teachable momentTobacco use statusCessation advicePharmacologic treatmentCessation treatmentWorse prognosisCessation interventionsCessation supportEfficient intervention strategies
2016
Pairing smoking‐cessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco
Fucito LM, Czabafy S, Hendricks PS, Kotsen C, Richardson D, Toll BA, Committee F. Pairing smoking‐cessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco. Cancer 2016, 122: 1150-1159. PMID: 26916412, PMCID: PMC4828323, DOI: 10.1002/cncr.29926.Peer-Reviewed Original ResearchConceptsLung cancer screeningSmoking cessation interventionUS Preventive Services Task ForceLow-dose computed tomographyCancer screeningSmoking cessationTobacco useEvidence-based smoking cessation interventionsAge 55Evidence-based smoking cessation treatmentLung cancer screening participantsAnnual lung cancerPatients age 55Pack-year historySmoking cessation effortsSmoking cessation servicesSmoking cessation treatmentHigh-risk groupEvidence-based treatmentsEvidence-based behavioral strategiesScreening participantsLung cancerClinical guidelinesClinical recommendationsPremature mortality
2014
Addressing the Evidence for FDA Nicotine Replacement Therapy Label Changes: A Policy Statement of the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco
Fucito LM, Bars MP, Forray A, Rojewski AM, Shiffman S, Selby P, West R, Foulds J, Toll BA, Networks W. Addressing the Evidence for FDA Nicotine Replacement Therapy Label Changes: A Policy Statement of the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco. Nicotine & Tobacco Research 2014, 16: 909-914. PMID: 24919399, PMCID: PMC6281057, DOI: 10.1093/ntr/ntu087.Peer-Reviewed Original ResearchConceptsQuit attemptsQuit dateSmoking reductionEffective smoking cessation interventionsSubstantial public health burdenAid smoking cessationNicotine patch useSmoking cessation interventionPublic health burdenShort-acting formsNRT formulationsNRT medicationsRecalcitrant smokersNicotine patchCessation interventionsCigarette smokingSmoking cessationHealth burdenProvider consultationTobacco useDrug AdministrationRelapse preventionSmokersLabeling changesMonths“Quitting Smoking Will Benefit Your Health”: The Evolution of Clinician Messaging to Encourage Tobacco Cessation
Toll BA, Rojewski AM, Duncan LR, Latimer-Cheung AE, Fucito LM, Boyer JL, O'Malley SS, Salovey P, Herbst RS. “Quitting Smoking Will Benefit Your Health”: The Evolution of Clinician Messaging to Encourage Tobacco Cessation. Clinical Cancer Research 2014, 20: 301-309. PMID: 24436474, PMCID: PMC3927319, DOI: 10.1158/1078-0432.ccr-13-2261.Peer-Reviewed Original ResearchConceptsCancer-related deathHeart diseaseTobacco useLung cancer-related deathsSubgroups of smokersBurden of cancerModerators of treatmentAdult patientsCessation interventionsSmoking cessationTobacco cessationQuitting smokingPreventable deathsGain-framed messagesSmokingTobacco productsCancerDiseaseDeathPatientsLungStrokeCessationHealthFuture studies